Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses

被引:9
|
作者
Macho-Fernandez, Elodie [1 ,2 ,3 ,4 ,5 ]
Chekkat, Neila [6 ]
Ehret, Christophe [6 ]
Thomann, Jean-Sebastien [6 ]
De Giorgi, Marcella [6 ]
Spanedda, Maria Vittoria [6 ]
Bourel-Bonnet, Line [6 ]
Betbeder, Didier [7 ,8 ]
Heurtault, Beatrice [6 ]
Faveeuw, Christelle [1 ,2 ,3 ,4 ,5 ]
Fournel, Sylvie [6 ]
Frisch, Benoit [6 ]
Trottein, Francois [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Lille, CIIL, U1019, UMR 8204, F-59000 Lille, France
[2] CNRS, UMR 8204, F-59000 Lille, France
[3] INSERM, U1019, F-59000 Lille, France
[4] CHU Lille, F-59000 Lille, France
[5] Inst Pasteur, F-59000 Lille, France
[6] Univ Strasbourg, CNRS, CAMB UMR 7199, F-67000 Strasbourg, France
[7] Univ Lille 2, CHRU Lille, INSERM, LIRIC,UMR 995, F-59045 Lille, France
[8] Univ Artois, F-62000 Arras, France
关键词
iNKT; alpha-GalCer formulations; Liposomes; Micelles; Water-soluble alpha-GalCer; Cancer; V-ALPHA-24-INVARIANT NKT CELLS; LUNG-CANCER PATIENTS; DENDRITIC CELLS; ANTIGEN PRESENTATION; VACCINE ADJUVANTS; PHASE-I; IMMUNITY; DELIVERY; INNATE; LIPOSOMES;
D O I
10.1016/j.ijpharm.2017.07.054
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The potent antitumor effect of alpha-galactosylceramide (alpha-GalCer) is based on its recognition by invariant Natural Killer T cells (iNKT) after its capture and presentation by antigen presenting cells including dendritic cells (DCs). Synthetic alpha-GalCer has already been tested in advanced cancer patients but no or only moderate clinical responses were obtained. To optimize alpha-GalCer efficacy, we have postulated that alternative formulations impacting its molecular organization in aqueous medium could modify DC uptake and iNKT-based immune responses. To this end, we have developed two strategies: (1) the formulation of alpha-GalCer in non-cationic liposomes and (2) the synthesis of a water-soluble alpha-GalCer analogue by anchoring a polyethyleneglycol moiety on its sugar head. The biological activities of these new preparations were compared to that induced by the classically used Polysorbate 20 alpha-GalCer micelles. Both formulations retained their uptake by DCs and activated iNKT cells both in vitro and in vivo. Despite a lower cytokine production, the formulations induced a potent immune response able to control lung murine carcinoma. In conclusion, it is possible to increase alpha-GalCer solubility in aqueous solution without limiting its antitumor properties. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:354 / 363
页数:10
相关论文
共 50 条
  • [21] Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza
    Barthelemy, Adeline
    Ivanov, Stoyan
    Hassane, Maya
    Fontaine, Josette
    Heurtault, Beatrice
    Frisch, Benoit
    Faveeuw, Christelle
    Paget, Christophe
    Trottein, Francois
    MBIO, 2016, 7 (06):
  • [22] Activation of natural killer T cells by α-galactosylceramide mediates clearance of bacteria in murine urinary tract infection
    Minagawa, S
    Ohyama, C
    Hatakeyama, S
    Tsuchiya, N
    Kato, T
    Habuchi, T
    JOURNAL OF UROLOGY, 2005, 173 (06): : 2171 - 2174
  • [23] Coincidence of autoantibody production with the activation of natural killer T cells in α-galactosylceramide-mediated hepatic injury
    Matsumoto, Hiroaki
    Kawamura, Toshihiko
    Kobayashi, Takahiro
    Kanda, Yasuhiro
    Kawamura, Hiroki
    Abo, Toru
    IMMUNOLOGY, 2011, 133 (01) : 21 - 28
  • [24] In-vivo stimulation of macaque natural killer T cells with -galactosylceramide
    Fernandez, C. S.
    Jegaskanda, S.
    Godfrey, D. I.
    Kent, S. J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 173 (03): : 480 - 492
  • [25] A Novel Method for Ex Vivo Stimulation of Mesenchymal Stem Cells via Invariant Natural Killer T Cell Activation with α-Galactosylceramide.
    Ishii, R.
    Kawaguchi, E.
    Yamakawa, T.
    Ishigooka, H.
    Ikeda, T.
    Ishiyama, R.
    Saiga, K.
    Takagi, T.
    Ishii, Y.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 898 - 899
  • [26] T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to α-galactosylceramide are impaired
    O'Keeffe, Joan
    Gately, Carol M.
    Counihan, Timothy
    Hennessy, Michael
    Leahy, Teresa
    Moran, Anthony P.
    Hogan, Edward L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 275 (1-2) : 22 - 28
  • [27] Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection
    Frank, Kayla
    Paust, Silke
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [28] Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
    Nakashima, Hiroyuki
    Kinoshita, Manabu
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [29] Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
    Shayan Sharif
    Guillermo A. Arreaza
    Peter Zucker
    Qing-Sheng Mi
    Jitin Sondhi
    Olga V. Naidenko
    Mitchell Kronenberg
    Yasuhiko Koezuka
    Terry L. Delovitch
    Jean-Marc Gombert
    Maria Leite-de-Moraes
    Christine Gouarin
    Ren Zhu
    Agathe Hameg
    Toshinori Nakayama
    Masaru Taniguchi
    Françoise Lepault
    Agnès Lehuen
    Jean-François Bach
    André Herbelin
    Nature Medicine, 2001, 7 : 1057 - 1062
  • [30] Amelioration of natural killer cell function driven by invariant natural killer T cell activation in multiple myeloma
    Yamasaki, Satoru
    Iyoda, Tomonori
    Hidaka, Michihiro
    Kawano, Fumio
    Abe, Yu
    Suzuki, Kenshi
    Kadowaki, Norimitsu
    Shimizu, Kanako
    Fujii, Shin-ichiro
    CANCER SCIENCE, 2018, 109 : 109 - 109